Prospective clinical assessment of patients with pulmonary arterial hypertension switched from bosentan to macitentan (POTENT)
Abstract Even though pulmonary arterial hypertension (PAH) remains an incurable disease, the combination of PAH‐specific therapies allowed treatment strategies to evolve from symptom‐based ones to others that aim to move patients to low‐risk conditions. Endothelin‐1 (ET‐1) receptor antagonists emerg...
Gardado en:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wiley
2022-04-01
|
| Series: | Pulmonary Circulation |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1002/pul2.12083 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|